317 related articles for article (PubMed ID: 15832090)
1. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions.
Bhattacharya B; Dilworth HP; Iacobuzio-Donahue C; Ricci F; Weber K; Furlong MA; Fisher C; Montgomery E
Am J Surg Pathol; 2005 May; 29(5):653-9. PubMed ID: 15832090
[TBL] [Abstract][Full Text] [Related]
2. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis.
Montgomery E; Torbenson MS; Kaushal M; Fisher C; Abraham SC
Am J Surg Pathol; 2002 Oct; 26(10):1296-301. PubMed ID: 12360044
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature.
Carlson JW; Fletcher CD
Histopathology; 2007 Oct; 51(4):509-14. PubMed ID: 17711447
[TBL] [Abstract][Full Text] [Related]
4. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway.
Abraham SC; Reynolds C; Lee JH; Montgomery EA; Baisden BL; Krasinskas AM; Wu TT
Hum Pathol; 2002 Jan; 33(1):39-46. PubMed ID: 11823972
[TBL] [Abstract][Full Text] [Related]
5. Superficial fibromatoses are genetically distinct from deep fibromatoses.
Montgomery E; Lee JH; Abraham SC; Wu TT
Mod Pathol; 2001 Jul; 14(7):695-701. PubMed ID: 11455002
[TBL] [Abstract][Full Text] [Related]
6. Beta-catenin expression in pediatric fibroblastic and myofibroblastic lesions: a study of 100 cases.
Thway K; Gibson S; Ramsay A; Sebire NJ
Pediatr Dev Pathol; 2009; 12(4):292-6. PubMed ID: 18939887
[TBL] [Abstract][Full Text] [Related]
7. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
[TBL] [Abstract][Full Text] [Related]
8. Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis.
Zhou L; Xu H; Zhou J; Dong L; Zhang P; Yang X; Wang C
Diagn Pathol; 2019 May; 14(1):34. PubMed ID: 31043173
[TBL] [Abstract][Full Text] [Related]
9. Utility of LEF1 to differentiate desmoid fibromatosis from its histologic mimics.
Jobbagy S; Lozano-Calderon S; Mullen JT; Nielsen GP; Hung YP; Chebib I
Virchows Arch; 2024 May; 484(5):807-813. PubMed ID: 38503969
[TBL] [Abstract][Full Text] [Related]
10. Nuclear β-catenin immunoexpression in scars.
Goto K; Ishikawa M; Aizawa D; Muramatsu K; Naka M; Sugino T
J Cutan Pathol; 2021 Jan; 48(1):18-23. PubMed ID: 32652763
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic expression of Wilms tumor transcription factor-1 (WT1): a useful immunomarker for young-type fibromatoses and infantile fibrosarcoma.
Magro G; Salvatorelli L; Vecchio GM; Musumeci G; Rita A; Parenti R
Acta Histochem; 2014 Sep; 116(7):1134-40. PubMed ID: 25005570
[TBL] [Abstract][Full Text] [Related]
12. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53.
Oshiro Y; Fukuda T; Tsuneyoshi M
Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104
[TBL] [Abstract][Full Text] [Related]
13. Pleuropulmonary desmoid tumors: immunohistochemical comparison with solitary fibrous tumors and assessment of beta-catenin and cyclin D1 expression.
Andino L; Cagle PT; Murer B; Lu L; Popper HH; Galateau-Salle F; Sienko AE; Barrios R; Zander DS
Arch Pathol Lab Med; 2006 Oct; 130(10):1503-9. PubMed ID: 17090192
[TBL] [Abstract][Full Text] [Related]
14. APC and beta-catenin in alveolar soft part sarcoma (ASPS)--immunohistochemical and molecular genetic analysis.
Kuhnen C; Herter P; Monse H; Kahmann S; Muehlberger T; Vogt PM; Steinau HU; Müller KM; Müller O
Pathol Res Pract; 2000; 196(5):299-304. PubMed ID: 10834386
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic and genetic studies of desmoid-type fibromatosis].
Yang JL; Wang J; Zhou XY; Li XQ; Hou YY; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):145-50. PubMed ID: 16630502
[TBL] [Abstract][Full Text] [Related]
16. Low-grade sarcomas with CD34-positive fibroblasts and low-grade myofibroblastic sarcomas.
Fisher C
Ultrastruct Pathol; 2004; 28(5-6):291-305. PubMed ID: 15764578
[TBL] [Abstract][Full Text] [Related]
17. Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas.
Kuhnen C; Herter P; Müller O; Muehlberger T; Krause L; Homann H; Steinau HU; Müller KM
Mod Pathol; 2000 Sep; 13(9):1005-13. PubMed ID: 11007041
[TBL] [Abstract][Full Text] [Related]
18. beta-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours.
Saito T; Oda Y; Tanaka K; Matsuda S; Tamiya S; Iwamoto Y; Tsuneyoshi M
J Pathol; 2001 Sep; 195(2):222-8. PubMed ID: 11592102
[TBL] [Abstract][Full Text] [Related]
19. Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma.
Karbova E; Davidson B; Metodiev K; Tropé CG; Nesland JM
Int J Surg Pathol; 2002 Jul; 10(3):175-80. PubMed ID: 12232570
[TBL] [Abstract][Full Text] [Related]
20. A subset of cranial fasciitis is associated with dysregulation of the Wnt/beta-catenin pathway.
Rakheja D; Cunningham JC; Mitui M; Patel AS; Tomlinson GE; Weinberg AG
Mod Pathol; 2008 Nov; 21(11):1330-6. PubMed ID: 18587328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
